The absence of typical pneumonia symptoms in a patient with rheumatoid arthritis during tocilizumab and steroid treatment

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Yanagawa, Youichi ^a   Hirano, Yohei ^a   Kato, Hiroshi ^b   Iba, Toshiaki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Ken O Tokorozawa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; IODINE; METHYLPREDNISOLONE; OXYGEN; TOCILIZUMAB;

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CASE REPORT; CHILL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; MALAISE; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SORE THROAT; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; URINE INCONTINENCE; VOMITING;

EID: 84863659978     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.02.2012.5835     Document Type: Article

References (6)

1. Conti B, Tabarean I, Andrei C, et al. Cytokines and fever. Front Biosci 2004;9:1433-49. (Pubitemid 39066207)
2. Weber J, Yang JC, Topalian SL, et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 1993;11:499-506. (Pubitemid 23071048)
3. Fujiwara H, Nishimoto N, Hamano Y, et al. Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment: a report of two cases. Mod Rheumatol 2009;19:64-8.
4. Yap SH, Moshage HJ, Hazenberg BP, et al. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochim Biophys Acta 1991;1091:405-8.
5. Szalai AJ, Briles DE, Volanakis JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995;155:2557-63.
6. Hoshi D, Nakajima A, Inoue E, et al. Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab. Mod Rheumatol 2012;22:122-7.